{"id":9073,"date":"2020-04-29T09:20:31","date_gmt":"2020-04-29T07:20:31","guid":{"rendered":"https:\/\/www.resist-cluster.de\/?page_id=9073"},"modified":"2022-02-02T13:24:00","modified_gmt":"2022-02-02T12:24:00","slug":"prof-dr-ulrich-kalinke","status":"publish","type":"page","link":"https:\/\/www.resist-cluster.de\/en\/about-us\/research-team-2\/prof-dr-ulrich-kalinke\/","title":{"rendered":"Prof. Dr. Ulrich Kalinke"},"content":{"rendered":"

<\/div>
<\/div>
<\/div>
<\/div>
<\/div>
<\/div>
<\/div><\/div><\/div>
<\/a><\/span><\/div>

Prof. Dr. Ulrich Kalinke participates in\u00a0RESIST research projects A4 and B9.<\/p>\n<\/div>

<\/div><\/div><\/div>

\n\n\n
<\/i><\/td>\nMy Research Interest in RESIST<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/h1><\/div>
\n
\n
\n

Our research focus in RESIST is to identify factors for Hepatitis B Virus (HBV) vaccination non- responsiveness in single individuals. Additionally, we strive towards a better understanding of how protective immunity against HBV is induced. In this regard, we intensively collaborate with clinical institutes and occupational health physicians of the MHH to ultimately generate a comprehensive model of HBV vaccination non-responsiveness to improve vaccination schemes for HBV vaccination non-responders and to develop innovative vaccination strategies.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>

<\/div>
<\/div>
<\/div>
<\/i><\/span>Contact<\/span><\/a><\/div>
<\/div><\/div><\/div><\/div><\/div>
<\/path><\/svg><\/div>
<\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div>
<\/div>
<\/div>
<\/div>
<\/div>
<\/div><\/div><\/div>
<\/div><\/div><\/div>

Prof. Kalinke about his scientific work<\/h1><\/div>